2.3 Equity, Diversity, Inclusion, Cultural Safety & Continuous Quality Improvement
Key Takeaways
The 2024 NAPRA Professional Competencies embed Equity, Diversity, Inclusion, and Cultural Safety, shifting clinical practice from passive cultural competence to active, lifelong cultural humility and trauma-informed care.
Addressing systemic anti-Indigenous racism requires honoring the Truth and Reconciliation Commission (TRC) Calls to Action (specifically 18-24), upholding Jordan's Principle to eliminate jurisdictional delays for First Nations children, and actively navigating Non-Insured Health Benefits (NIHB).
2SLGBTQIA+ affirmative care means using chosen names and pronouns regardless of legal documentation and managing gender-affirming hormone therapy with vigilant monitoring of hematocrit, venous thromboembolism risk, potassium, and bone health.
A Just Culture categorizes actions into human error (console), at-risk behavior (coach), and reckless behavior (sanction), pairing continuous quality improvement (CQI) with anonymous reporting to CMIRPS/ISMP Canada (required by several provincial CQI programs) and multidisciplinary Root Cause Analysis.
Equity, Diversity, Inclusion, Cultural Safety & Continuous Quality Improvement
Contemporary Canadian pharmacy practice is built on dual commitments to social accountability and system-level medication safety. The 2024 NAPRA Entry-to-Practice Competencies mandate that pharmacists actively address health inequities, deliver culturally safe and trauma-informed care, and champion continuous quality improvement (CQI) within an institutional "Just Culture."
1. 2024 NAPRA Mandate: Cultural Humility, Cultural Safety & Trauma-Informed Care
Healthcare across Canada historically treated cultural education through the lens of cultural competence—an outdated model that assumed a practitioner could achieve an end-state mastery of beliefs and traditions associated with specific ethnic or social groups. Modern practice rejects this approach in favor of Cultural Humility and Cultural Safety:
- Cultural Humility: A lifelong process of self-reflection, self-critique, and openness. It requires practitioners to examine their own unconscious biases, acknowledge personal limitations in understanding another person's lived experience, and intentionally redress power imbalances inherent in the practitioner-patient dynamic.
- Cultural Safety: An outcome defined and experienced by the recipient of care. A culturally safe healthcare environment is one that is spiritually, socially, emotionally, and physically safe, where individuals feel respected and free from discrimination, stereotyping, racism, or historical denial of their identity.
- Trauma-Informed Care (TIC): A service delivery framework recognizing the widespread prevalence of psychological and physical trauma. TIC emphasizes five core principles across all clinical encounters:
- Safety: Ensuring physical and emotional safety in the pharmacy (e.g., private consultation rooms, predictable interactions).
- Trustworthiness & Transparency: Maintaining transparent communication about medications, adverse effects, costs, and documentation.
- Collaboration & Mutuality: Partnering with the patient, sharing decision-making power rather than dictating therapy.
- Empowerment & Choice: Validating the patient's voice, prioritizing consent, and offering treatment alternatives.
- Cultural, Historical & Gender Awareness: Acknowledging systemic oppression and offering care responsive to diverse lived experiences.
2. Indigenous Health Equity & Systemic Reform
Indigenous peoples in Canada (First Nations, Inuit, and Métis) experience documented, persistent health inequities rooted in the ongoing impacts of colonization, forced displacement, the Indian Residential School system, and systemic anti-Indigenous racism in healthcare institutions (as evidenced in public inquiries such as the deaths of Brian Sinclair and Joyce Echaquan).
Truth and Reconciliation Commission (TRC) Calls to Action
The Truth and Reconciliation Commission of Canada (TRC) delivered 94 Calls to Action to redress the legacy of residential schools and advance reconciliation. Calls to Action 18 through 24 specifically address health:
- Call 18: Acknowledge that the current state of Indigenous health in Canada is a direct result of Canadian government policies, including residential schools.
- Call 19: Establish measurable goals to identify and close the gaps in health outcomes between Indigenous and non-Indigenous communities, including infant mortality, maternal health, suicide, mental health, addiction, and chronic disease rates.
- Call 22: Recognize the value of Indigenous healing practices and traditional medicines, integrating them into treatment plans in collaborative partnership with Indigenous healers and Elders.
- Call 23: Increase the number of Indigenous professionals working in health care, ensure their retention in Indigenous communities, and provide cultural competency training for all healthcare professionals.
- Call 24: Require all medical and nursing school students to take a course on Indigenous health issues, including the history and legacy of residential schools, the United Nations Declaration on the Rights of Indigenous Peoples (UNDRIP), Treaties and Aboriginal rights, and Indigenous teachings and practices, with skills-based training in intercultural competency, conflict resolution, human rights, and anti-racism.
Jordan's Principle
Jordan's Principle is a child-first legal principle established in memory of Jordan River Anderson, a First Nations child who spent years needlessly hospitalized while federal and provincial governments disputed which level of government was responsible for paying for his at-home medical care.
- Legal Rule: Jordan's Principle ensures that First Nations children living on or off reserve can access all public services (including healthcare, medications, medical equipment, and mental health supports) without denial, delay, or disruption.
- Application in Pharmacy: The government of first contact must pay for the child's medication or medical supply immediately. Jurisdictional or bureaucratic disputes regarding whether the federal or provincial government is financially liable must be resolved afterward, ensuring the child's care is never interrupted.
Non-Insured Health Benefits (NIHB) Navigation
The Non-Insured Health Benefits (NIHB) program is a federal program that provides eligible First Nations and Inuit clients with coverage for a specified range of medically necessary health benefits not covered through private or provincial plans (including prescription drugs, OTC products, medical supplies, and dental care). Pharmacists have a professional obligation to navigate NIHB formularies, advocate for client coverage through prior approval requests, and prevent administrative barriers from disrupting therapy.
3. 2SLGBTQIA+ Affirmative Care & Gender-Affirming Pharmacotherapy
Pharmacists deliver affirmative care to Two-Spirit, Lesbian, Gay, Bisexual, Transgender, Queer, Intersex, and Asexual (2SLGBTQIA+) patients by establishing welcoming environments, using gender-neutral intake forms, verifying pronouns, and respecting chosen names. Crucially, a patient's chosen name and pronouns should be used in all personal interactions, regardless of whether their legal documentation or provincial health insurance card has been updated. Many pharmacy systems can also show the chosen name on labels and profiles, while the legal name stays linked for billing and identity checks. Ask the patient how they want their name to appear.
Gender-Affirming Hormone Therapy (GAHT) Clinical Management
Pharmacists play a central role in dispensing, monitoring, and counseling patients undergoing gender-affirming hormone therapy:
| Regimen Category | Medications & Mechanism | Therapeutic Goals | Crucial Monitoring Parameters & Adverse Risks |
|---|---|---|---|
| Feminizing Therapy (Estrogens) | 17-Beta Estradiol (oral, sublingual, transdermal patch, IM valerate/cypionate) | Induces female secondary sex characteristics (breast development, body fat redistribution, reduced facial hair growth). | Venous Thromboembolism (VTE): Transdermal estradiol preferred in patients age >40, smokers, or those with cardiovascular risk factors (bypasses hepatic first-pass); Hyperprolactinemia (monitor prolactin if symptomatic headaches/visual changes); Cholelithiasis, elevated triglycerides. |
| Feminizing Therapy (Anti-Androgens) | Spironolactone (aldosterone antagonist; blocks androgen receptors); Cyproterone Acetate (progestin anti-androgen); GnRH Agonists (leuprolide) | Suppresses endogenous testosterone synthesis and blocks androgenic receptors. | Spironolactone: Hyperkalemia, hypotension (monitor baseline and ongoing serum potassium, blood pressure, SCr); Cyproterone: Hepatotoxicity, vitamin B12 deficiency, hyperprolactinemia, meningioma risk at high cumulative doses. |
| Masculinizing Therapy (Androgens) | Testosterone (IM/SC cypionate or enanthate, transdermal gel) | Induces virilization (voice deepening, clitoromegaly, facial/body hair, cessation of menses). | Erythrocytosis: Elevated hemoglobin/hematocrit (>0.50–0.54 increases blood viscosity and thromboembolic risk; requires dose reduction or phlebotomy); Lipid panel changes (decreased HDL, increased LDL); Teratogenicity: Pregnancy must be ruled out; non-hormonal contraception advised if having receptive penile-vaginal intercourse. |
4. Continuous Quality Improvement (CQI) in Canadian Pharmacy
Continuous Quality Improvement (CQI) is a structured, organizational approach to medication safety mandated by provincial pharmacy regulatory authorities (such as Ontario's Assurance and Improvement in Medication Safety [AIMS] program, Nova Scotia's SafetyNET-Rx, and equivalent frameworks in Alberta, Saskatchewan, Manitoba, and BC).
Four Core Pillars of a CQI Program
FOUR CORE PILLARS OF CQI
1. INCIDENT DOCUMENTATION Meticulously record all medication incidents (adverse drug events, dispensing
errors) and near misses (good catches) in a standardized internal log.
│
▼
2. MANDATORY REPORTING Anonymously report incidents to an independent national/provincial database
(e.g., CMIRPS via ISMP Canada) to contribute to aggregate safety data.
│
▼
3. SYSTEMIC ANALYSIS Conduct formal multi-disciplinary Root Cause Analysis (RCA) or quarterly
incident reviews to uncover underlying latent system failures.
│
▼
4. QUALITY PLAN & AUDIT Design and implement system-level safeguards (e.g., forcing functions, barcode
scanning, shelf separation) and continuously audit outcomes.
- Canadian Medication Incident Reporting and Prevention System (CMIRPS): A collaborative pan-Canadian initiative involving Health Canada, the Institute for Safe Medication Practices Canada (ISMP Canada), the Canadian Institute for Health Information (CIHI), and Healthcare Excellence Canada. Pharmacists submit anonymous incident reports to ISMP Canada to drive national medication safety alerts.
5. Incident Analysis Methodologies: RCA vs. FMEA
When evaluating risk and preventing medication incidents, pharmacy teams utilize two complementary analytical methodologies:
| Dimension | Root Cause Analysis (RCA) | Failure Mode and Effects Analysis (FMEA) |
|---|---|---|
| Timing & Focus | Retrospective: Conducted after a serious medication incident or sentinel event has occurred. | Prospective: Conducted proactively before introducing a new technology, workflow, or high-risk drug. |
| Primary Objective | Identify the root systemic causes and latent failures that allowed the incident to happen. | Identify potential failure modes, causes, and consequences to build safeguards before failure occurs. |
| Analytical Tools | The "5 Whys" technique; Fishbone (Ishikawa) diagram (People, Environment, Equipment, Procedures); Causal timeline mapping | Process flowcharts; Risk Priority Number (RPN = Severity × Occurrence × Detection) |
| Outcome | Action plan to remediate system weaknesses and prevent recurrence of the specific failure. | Error-proofing process redesign (e.g., automated forcing functions, double-checks) prioritized by RPN. |
6. "Just Culture" Principles in Safety Management
Historically, healthcare treated medication errors under a punitive "blame-and-shame" model that targeted individual practitioners. This approach suppressed error reporting, fostered fear, and left underlying system flaws unaddressed. Modern safety culture operates under Just Culture principles, which draw a clear, fair line between human error, behavioral drift, and gross disregard for safety:
JUST CULTURE BEHAVIORAL MATRIX
┌─────────────────────────┬──────────────────────────────────────┬──────────────────────────────┐
│ BEHAVIOR CATEGORY │ DEFINITION │ ORGANIZATIONAL RESPONSE │
├─────────────────────────┼──────────────────────────────────────┼──────────────────────────────┤
│ 1. HUMAN ERROR │ Inadvertent slips, lapses, or honest │ CONSOLE THE PRACTITIONER │
│ │ mistakes during routine execution. │ Redesign systems, packaging, │
│ │ (e.g., misreading look-alike label). │ lighting, or workflow. │
├─────────────────────────┼──────────────────────────────────────┼──────────────────────────────┤
│ 2. AT-RISK BEHAVIOR │ Behavioral drift; choosing a shortcut│ COACH THE PRACTITIONER │
│ │ where risk is mistakenly believed to │ Retrain on safety mechanisms;│
│ │ be insignificant or justified. │ remove incentives for speed. │
├─────────────────────────┼──────────────────────────────────────┼──────────────────────────────┤
│ 3. RECKLESS BEHAVIOR │ Conscious disregard of a substantial │ DISCIPLINARY SANCTIONS │
│ │ and unjustifiable risk. │ Remedial action, suspension, │
│ │ (e.g., dispensing while intoxicated).│ or regulatory college report.│
└─────────────────────────┴──────────────────────────────────────┴──────────────────────────────┘
Note
A Just Culture does not mean a "blame-free" culture. While human error is met with system redesign and support, deliberate reckless behavior that knowingly endangers patients remains subject to professional discipline and regulatory accountability.
During a high-volume dispensary shift, a registered pharmacy technician deliberately bypasses the barcode scanning verification step for several repeat refill prescriptions, believing that doing so is necessary to meet hourly wait-time targets. An incorrect dosage strength reaches a patient, resulting in a near miss that is caught before ingestion. Under Just Culture principles, how should the pharmacy manager classify the technician's actions and respond?
Classify the action as at-risk behavior, provide supportive coaching to address the behavioral drift, and eliminate organizational pressures that prioritize dispensing speed over safety verification.
Classify the action as an unpreventable human error, console the technician, and make no changes to dispensary workflow.
Classify the action as reckless behaviour, immediately terminate the technician's employment, and report them to the provincial regulatory college for professional misconduct.
Classify the action as gross negligence, mandate a personal monetary fine, and suspend barcode scanning requirements across the dispensary.
A 22-year-old transgender man who has been taking intramuscular testosterone cypionate 100 mg weekly for 12 months presents to the pharmacy clinic for medication review. His latest blood work reveals a hematocrit of 0.55 (55%; reference range for adult males 0.40–0.50) and hemoglobin of 185 g/L (reference range 135–175 g/L). He reports mild headaches but has no other acute symptoms. What is the most appropriate clinical evaluation and pharmacotherapeutic recommendation?
Switch the patient from intramuscular testosterone to oral methyltestosterone to minimize bone marrow stimulation.
Reassure the patient that a hematocrit up to 0.60 is expected and benign during masculinizing hormone therapy, requiring no dosage change or additional laboratory monitoring.
Immediately discontinue testosterone therapy permanently because erythrocytosis is an irreversible oncologic complication of androgen treatment.
Recognize testosterone-induced erythrocytosis, recommend a lower dose, and discuss possible phlebotomy with the prescriber.
Sections you finish are checked off in the contents.